Page last updated: 2024-09-03

3-quinuclidinyl-4-iodobenzilate and Aging

3-quinuclidinyl-4-iodobenzilate has been researched along with Aging in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ell, PJ; Erlandsson, K; Murphy, DG; Norbury, R; Owens, J; Travis, MJ; Waddington, W1
Ell, PJ; Erlandsson, K; Murphy, DG; Norbury, R; Travis, MJ; Waddington, W1

Trials

2 trial(s) available for 3-quinuclidinyl-4-iodobenzilate and Aging

ArticleYear
SPET imaging of central muscarinic receptors with (R,R)[123I]-I-QNB: methodological considerations.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:5

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Brain; Female; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Quinuclidinyl Benzilate; Radiopharmaceuticals; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2004
Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study.
    Hormones and behavior, 2007, Volume: 51, Issue:2

    Topics: Adult; Aged; Aging; Analysis of Variance; Brain; Cognition; Estrogen Replacement Therapy; Female; Humans; Iodine Radioisotopes; Middle Aged; Postmenopause; Quinuclidinyl Benzilate; Receptors, Muscarinic; Reference Values; Statistics, Nonparametric; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Verbal Learning

2007